Blood-brain barrier (BBB) damage significantly affects the prognosis of ischemic stroke patients. This project employed multi-omics analysis to identify key factors regulating BBB disruption during cerebral ischemia-reperfusion. An integrated analysis of three transcriptome sequencing datasets from mouse middle cerebral artery occlusion/reperfusion (MCAO/R) models identified eight downregulated genes in endothelial cells. Additionally, transcriptome analysis of BBB (cortex) and non-BBB (lung) endothelium of E13.5 mice revealed 2,102 upregulated genes potentially associated with BBB integrity. The eight downregulated genes were intersected with the 2,102 BBB-related genes and mapped using single-cell RNA sequencing data, revealing that solute carrier family 22 member 8 (Slc22a8) is specifically expressed in endothelial cells and pericytes and significantly decreases after MCAO/R. This finding was validated in the mouse MCAO/R model at both protein and mRNA levels in this study. External overexpression of Slc22a8 using a lentivirus carrying Tie2 improved Slc22a8 and tight junction protein levels and reduced BBB leakage after MCAO/R, accompanied by Wnt/β-catenin signaling activation. In conclusion, this study suggested that MCAO/R-induced downregulation of Slc22a8 expression may be a crucial mechanism underlying BBB disruption. Interventions that promote Slc22a8 expression or enhance its function hold promise for improving the prognosis of patients with cerebral ischemia.
TuWJZhaoZPYinP, et al.
Estimated burden of stroke in China in 2020. JAMA Netw Open2023;
6: e231455.
2.
WalterK.What is acute ischemic stroke?JAMA2022;
327: 885.
3.
WidimskyPSnyderKSulzenkoJ, et al.
Acute ischaemic stroke: recent advances in reperfusion treatment. Eur Heart J2023;
44: 1205–1215.
4.
EltzschigHKEckleT.Ischemia and reperfusion – from mechanism to translation. Nat Med2011;
17: 1391–1401.
5.
DirnaglUIadecolaCMoskowitzMA.Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci1999;
22: 391–397.
6.
ZhouYHeYDYanSQ, et al.
Reperfusion injury is associated with poor outcome in patients with recanalization after thrombectomy. Stroke2023;
54: 96–104.
7.
LangenUHAylooSGuCH.Development and cell biology of the blood-brain barrier. In: LehmannR (ed.) Annual review of cell and developmental biology. Vol 35.
Palo Alto:
Annual Reviews, 2019, pp. 591–613.
8.
KutuzovNFlyvbjergHLauritzenM.Contributions of the glycocalyx, endothelium, and extravascular compartment to the blood-brain barrier. Proc Natl Acad Sci U S A2018;
115: E9429–E9438.
9.
HuntleyMABien-LyNDanemanR, et al.
Dissecting gene expression at the blood-brain barrier. Front Neurosci2014;
8: 355.
10.
SaundersNRHabgoodMDDziegielewskaKM.Barrier mechanisms in the brain, II. Immature brain. Clin Exp Pharmacol Physiol1999;
26: 85–91.
11.
SaundersNRDanemanRDziegielewskaKM, et al.
Transporters of the blood-brain and blood-CSF interfaces in development and in the adult. Mol Aspects Med2013;
34: 742–752.
12.
KolárováHAmbruzováBSindlerováLS, et al.
Modulation of endothelial glycocalyx structure under inflammatory conditions. Mediat Inflamm2014;
2014: 17.
13.
ZhengDDLiuJPiaoHL, et al.
ROS-triggered endothelial cell death mechanisms: focus on pyroptosis, parthanatos, and ferroptosis. Front Immunol2022;
13: 1039241.
14.
BallabhPBraunANedergaardM.The blood-brain barrier: an overview – structure, regulation, and clinical implications. Neurobiol Dis2004;
16: 1–13.
15.
LiebnerSDijkhuizenRMReissY, et al.
Functional morphology of the blood-brain barrier in health and disease. Acta Neuropathol2018;
135: 311–336.
16.
YangCJHawkinsKEDoreS, et al.
Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke. Am J Physiol Cell Physiol2019;
316: C135–C153.
17.
del ZoppoGJSaverJLJauchEC, et al.
Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator a science advisory from the American Heart Association/American Stroke Association. Stroke2009;
40: 2945–2948.
18.
WangXYTsujiKLeeSR, et al.
Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke. Stroke2004;
35: 2726–2730.
19.
AbdullahiWTripathiDRonaldsonPT.Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection. Am J Physiol Cell Physiol2018;
315: C343–C356.
20.
ZhengKLinLMJiangW, et al.
Single-cell RNA-seq reveals the transcriptional landscape in ischemic stroke. J Cereb Blood Flow Metab2022;
42: 56–73.
21.
ZengFNCaoJHongZX, et al.
Single-cell analyses reveal the dynamic functions of Itgb2(+) microglia subclusters at different stages of cerebral ischemia-reperfusion injury in transient middle cerebral occlusion mice model. Front Immunol2023;
14: 1114663.
22.
Ben-ZviALacosteBKurE, et al.
Mfsd2a is critical for the formation and function of the blood-brain barrier. Nature2014;
509: 507–511.
23.
NigamSKBushKTMartovetskyG, et al.
The organic anion transporter (oat) family: a systems biology perspective. Physiol Rev2015;
95: 83–123.
24.
HaratiRBenechHVillegierAS, et al.
P-glycoprotein, breast cancer resistance protein, organic anion transporter 3, and transporting peptide 1a4 during blood-brain barrier maturation: involvement of wnt/beta-catenin and endothelin-1 signaling. Mol Pharm2013;
10: 1566–1580.
25.
SpitzerDGueritSPuetzT, et al.
Profiling the neurovascular unit unveils detrimental effects of osteopontin on the blood-brain barrier in acute ischemic stroke. Acta Neuropathol2022;
144: 305–337.
26.
SquairJWGautierMKatheC, et al.
Confronting false discoveries in single-cell differential expression. Nat Commun2021;
12: 5692.
27.
LongaEZWeinsteinPRCarlsonS, et al.
Middle cerebral-artery occlusion without craniectomy in rats. Stroke1989;
20: 84–91.
28.
ShiLGSunZYSuW, et al.
Treg cell-derived osteopontin promotes microglia-mediated white matter repair after ischemic stroke. Immunity2021;
54: 1527–1542.e8.
29.
ZhangHLiuDXuQ-F, et al.
Endothelial RSPO3 mediates pulmonary endothelial regeneration by LGR4-dependent activation of beta-catenin and ILK signaling pathways after inflammatory vascular injury. Int J Biol Macromol2024;
269: 131805.
30.
LiHYLiXXuZM, et al.
Unbalanced regulation of Sec22b and Ykt6 blocks autophagosome axonal retrograde flux in neuronal ischemia-reperfusion injury. J Neurosci2022;
42: 5641–5654.
31.
XuHCCaoYLYangX, et al.
ADAMTS13 controls vascular remodeling by modifying VWF reactivity during stroke recovery. Blood2017;
130: 11–22.
32.
WangRRZhuYBLiuZW, et al.
Neutrophil extracellular traps promote tPA-induced brain hemorrhage via cGAS in mice with stroke. Blood2021;
138: 91–103.
33.
KnowlandDAracASekiguchiKJ, et al.
Stepwise recruitment of transcellular and paracellular pathways underlies blood-brain barrier breakdown in stroke. Neuron2014;
82: 603–617.
34.
FaulFErdfelderELangA-G, et al.
G*power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods2007;
39: 175–191.
35.
VanlandewijckMHeLQMäeMAA, et al.
A molecular atlas of cell types and zonation in the brain vasculature. Nature2018;
554: 475–480.
36.
KaluckaJde RooijLGoveiaJ, et al.
Single-cell transcriptome atlas of murine endothelial cells. Cell2020;
180: 764–779.e20.
37.
SaundersAMacoskoEZWysokerA, et al.
Molecular diversity and specializations among the cells of the adult mouse brain. Cell2018;
174: 1015–1030.e16.
38.
WinklerEAKimCNRossJM, et al.
A single-cell atlas of the normal and malformed human brain vasculature. Science2022;
375: eabi7377.
39.
ZeiselAMuñoz-ManchadoABCodeluppiS, et al.
Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq. Science2015;
347: 1138–1142.
40.
ChenZHWangXWuHY, et al.
X-box binding protein 1 as a key modulator in “healing endothelial cells”, a novel EC phenotype promoting angiogenesis after MCAO. Cell Mol Biol Lett2022;
27: 97.
41.
WangYSChoCWilliamsJ, et al.
Interplay of the norrin and Wnt7a/Wnt7b signaling systems in blood-brain barrier and blood-retina barrier development and maintenance. Proc Natl Acad Sci U S A2018;
115: E11827–E11836.
LiebnerSCoradaMBangsowT, et al.
Wnt/β-catenin signaling controls development of the blood-brain barrier. J Cell Biol2008;
183: 409–417.
44.
ZhouYLWangYSTischfieldM, et al.
Canonical WNT signaling components in vascular development and barrier formation. J Clin Invest2014;
124: 3825–3846.
45.
DanemanRAgalliuDZhouL, et al.
Wnt/β-catenin signaling is required for CNS, but not non-CNS, angiogenesis. Proc Natl Acad Sci U S A2009;
106: 641–646.
46.
ChoCSmallwoodPMNathansJ.Reck and Gpr124 are essential receptor cofactors for Wnt7a/Wnt7b-specific signaling in mammalian CNS angiogenesis and blood-brain barrier regulation. Neuron2017;
95: 1056–1073.e5.
47.
ZhouYLNathansJ.Gpr124 controls CNS angiogenesis and blood-brain barrier integrity by promoting ligand-specific canonical wnt signaling. Dev Cell2014;
31: 248–256.
48.
BirdseyGMDrydenNHAmsellemV, et al.
Transcription factor erg regulates angiogenesis and endothelial apoptosis through VE-cadherin. Blood2008;
111: 3498–3506.
49.
NiehrsCShenJL.Regulation of Lrp6 phosphorylation. Cell Mol Life Sci2010;
67: 2551–2562.
50.
DanemanRPratA.The blood-brain barrier. Cold Spring Harb Perspect Biol2015;
7: a020412.
51.
ZlokovicBV.The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron2008;
57: 178–201.
52.
ReeseTSKarnovskM.Fine structural localization of a blood-brain barrier to exogenous peroxidase. Anat Rec1967;
157: 306.
53.
SiegenthalerJASohetFDanemanR. ‘
Sealing off the CNS’: cellular and molecular regulation of blood-brain barriergenesis. Curr Opin Neurobiol2013;
23: 1057–1064.
54.
LiRJLiuYLWuJH, et al.
Adaptive metabolic responses facilitate blood-brain barrier repair in ischemic stroke via BHB-mediated epigenetic modification of ZO-1 expression. Adv Sci (Weinh)2024; e2400426.
55.
ZhengXYRenBDGaoY.Tight junction proteins related to blood-brain barrier and their regulatory signaling pathways in ischemic stroke. Biomed Pharmacother2023;
165: 115272.
56.
ChenYLinLBhuiyanMIH, et al.
Transient ischemic stroke triggers sustained damage of the choroid plexus blood-CSF barrier. Front Cell Neurosci2023;
17: 1279385.
57.
WuWJamshidiNEralySA, et al.
Multispecific drug transporter Slc22a8 (Oat3) regulates multiple metabolic and signaling pathways. Drug Metab Dispos2013;
41: 1825–1834.
58.
KikuchiTOkamuraTWakizakaH, et al.
OAT3-mediated extrusion of the Tc-99m-ECD metabolite in the mouse brain. J Cereb Blood Flow Metab2014;
34: 585–588.
59.
OhtsukiSAsabaHTakanagaH, et al.
Role of blood-brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain. J Neurochem2002;
83: 57–66.
60.
NagleMAWuWEralySA, et al.
Organic anion transport pathways in antiviral handling in choroid plexus in Oat1 (Slc22a6) and Oat3 (Slc22a8) deficient tissue. Neurosci Lett2013;
534: 133–138.
61.
OseAItoMKusuharaH, et al.
Limited brain distribution of 3R,4R,5S-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate (Ro 64-0802), a pharmacologically active form of oseltamivir, by active efflux across the blood-brain barrier mediated by organic anion transporter 3 (Oat3/Slc22a8) and multidrug resistance-associated protein 4 (Mrp4/Abcc4). Drug Metab Dispos2009;
37: 315–321.
62.
StenmanJMRajagopalJCarrollTJ, et al.
Canonical wnt signaling regulates organ-specific assembly and differentiation of CNS vasculature. Science2008;
322: 1247–1250.
63.
SongSSHuangHCGuanXD, et al.
Activation of endothelial wnt/β-catenin signaling by protective astrocytes repairs BBB damage in ischemic stroke. Prog Neurobiol2021;
199: 101963.
64.
LeBlancNJMenetRPicardK, et al.
Canonical wnt pathway maintains blood-brain barrier integrity upon ischemic stroke and its activation ameliorates tissue plasminogen activator therapy. Mol Neurobiol2019;
56: 6521–6538.
65.
ChenXYWanSFYaoNN, et al.
Inhibition of the immunoproteasome LMP2 ameliorates ischemia/hypoxia-induced blood-brain barrier injury through the wnt/β-catenin signalling pathway. Military Med Res2021;
8: 16.
66.
SalehiAJullienneABaghchechiM, et al.
Up-regulation of wnt/β-catenin expression is accompanied with vascular repair after traumatic brain injury. J Cereb Blood Flow Metab2018;
38: 274–289.
67.
AppukuttanBMcFarlandTJDaviesMH, et al.
Identification of novel alternatively spliced isoforms of RTEF-1 within human ocular vascular endothelial cells and murine retina. Invest Ophthalmol Vis Sci2007;
48: 3775–3782.
68.
ShieJLWuGFWuJP, et al.
RTEF-1, a novel transcriptional stimulator of vascular endothelial growth factor in hypoxic endothelial cells. J Biol Chem2004;
279: 25010–25016.
69.
ZhangYQZhaoBCLaiQ, et al.
Chronic cerebral hypoperfusion and blood-brain barrier disruption in uninjured brain areas of rhesus monkeys subjected to transient ischemic stroke. J Cereb Blood Flow Metab2022;
42: 1335–1346.
70.
StantonJAWilliamsEIBettertonRD, et al.
Targeting organic cation transporters at the blood-brain barrier to treat ischemic stroke in rats. Exp Neurol2022;
357: 114181.
71.
WilliamsEIBettertonRDStantonJA, et al.
Oatp (organic anion transporting polypeptide)-mediated transport: a mechanism for atorvastatin neuroprotection in stroke. Stroke2023;
54: 2875–2885.
72.
MandevilleETBuchanAMTiedtS.Not open and shut: Complex and prolonged blood-brain barrier responses after stroke. J Cereb Blood Flow Metab2024;
44: 446–448.
73.
NillesKLWilliamsEIBettertonRD, et al.
Blood-brain barrier transporters: opportunities for therapeutic development in ischemic stroke. Int J Mol Sci2022;
23: 31.
74.
ArmulikAGenovéGMäeM, et al.
Pericytes regulate the blood-brain barrier. Nature2010;
468: 557–561.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
